MRNA: Redburn reiterates sell, PT 81
Redburn calls the Phase 3 melanoma vaccine result “a great result,” but says the stock prices in broad multi-tumor use without supporting data.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Redburn calls the Phase 3 melanoma vaccine result “a great result,” but says the stock prices in broad multi-tumor use without supporting data.